SAN DIEGO, June 11, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina’s Chief Executive Officer and as a Director,…
Comments Off on Illumina announces CEO transition plan
· En parallèle de la conférence de Bonn sur le changement climatique (SB58), la présidence de la COP28 a organisé le bilan de la jeunesse afin d’évaluer les défis et les possibilités d’améliorer l’inclusion des jeunes dans les négociations sur les questions climatiques · En prévision de…
Comments Off on LORS DU « BILAN DE LA JEUNESSE » TENU EN PARALLÈLE DE LA SB58, LA PRÉSIDENCE DE LA COP28 SOULIGNE LA NÉCESSITÉ D’AMÉLIORER L’INCLUSION DES JEUNES ET ANNONCE LES 100 JEUNES DÉLÉGUÉS INTERNATIONAUX POUR LE CLIMAT
ORLANDO, Fla., June 11, 2023 /PRNewswire/ — SafePaaS, the leading Policy-based Access Governance platform and a sponsor of Ascend 2023 announces its Unified Data Access Governance solution for Oracle Cloud Infrastructure. The solution allows Oracle customers using ERP systems such as…
Comments Off on SafePaaS announces its Unified Data Access Governance (UDAG) offering for Oracle Cloud Infrastructure (OCI) at Ascend 2023
OPPO, official global partner of the UEFA Champions League, together with the legendary Kaká provided unforgettable experiences for football fans during the 2023 UEFA Champions League final in Istanbul The OPPO Hospitality Tent offered selected guests an immersive experience with props,…
Comments Off on OPPO and Global Brand Ambassador Kaká Inspire Miracles with Unmatched Experiences at the 2023 UEFA Champions League Final
HAMBURG, Germany, June 11, 2023 /PRNewswire/ — A ground-breaking study was presented 10 June at the Hybrid Congress in Hamburg organized by the European Academy of Allergy & Clinical Immunology (EAACI). Study was conducted by researchers from King’s College London and Guy’s and St…
Comments Off on Annual Congress 2023 of the European Academy of Allergy and Clinical Immunology: Study Shows Promising Results for Immunotherapy Targeting Skin Cancer
Údaje ukazujú významné 71 % zníženie rizika progresie ochorenia alebo úmrtia v skupine selinexor + bortezomib + dexametazón (SVd) v porovnaní so skupinou bortezomib + dexametazón (Vd) pri pacientoch bez predchádzajúcej liečby inhibítormi proteazómu (PI) Údaje ukazujú významné 47 %…
Comments Off on Menarini Group predstavila na kongrese Európskej hematologickej asociácie údaje o podskupine NEXPOVIO® (selinexor) zo štúdie BOSTON, ktoré poukazujú na klinický potenciál preparátu pri recidivujúcom/refraktérnom mnohopočetnom myelóme
STOCKHOLM, June 10, 2023 /PRNewswire/ — The hygiene and health company Essity divests its operations in Russia. Essity has signed an agreement with a buyer and the transaction has now been approved by the Russian authorities. The transaction is expected to be finalized during the second…
Comments Off on Essity divests Russian operations
STOCKHOLM, June 10, 2023 /PRNewswire/ — The hygiene and health company Essity divests its operations in Russia. Essity has signed an agreement with a buyer and the transaction has now been approved by the Russian authorities. The transaction is expected to be finalized during the second…
Comments Off on Essity divests Russian operations
NEW YORK, June 10, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Chinook Therapeutics, Inc. (“Chinook” or the “Company”) (NASDAQ: KDNY). If you suffered losses exceeding $50,000 investing in Chinook stock or…
Comments Off on CHINOOK SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Chinook To Contact Him Directly To Discuss Their Options
NEW YORK, June 10, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against First Horizon Corporation (“First Horizon” or the “Company”) (NYSE: FHN) and reminds investors of the July 21, 2023 deadline to seek the role of…
Comments Off on FIRST HORIZON SHAREHOLDER ACTION REMINDER : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In First Horizon To Contact Him Directly To Discuss Their Options
« Previous Page —
Next Page »